+1-800-267-5763
DOVS/TOS EVENT – IN-PERSON – Compliment Inhibition for Geographic Atrophy – Truth versus Rhetoric
Date: Thursday May 18, 2023
Time: 5:30 PM – 9:30 PM
Location: Hart House, 7 Hart House Circle, Toronto, ON M5S 3H3
*Please arrive early to perform a Rapid Antigen Test at the door, or you may perform one at home prior to arriving and take a date/time-stamped picture of your result*
Topic: Compliment Inhibition for Geographic Atrophy – Truth versus Rhetoric
Speakers: Drs. Rick Spaide and Caroline Baumal
Click here for more information
UoT – Department of Ophthalmology and Vision Sciences’ 65th Annual Research Day – IN PERSON
Date: Friday May 26, 2023
Location:
Peter Gilgan Centre for Research and Learning
Hospital for Sick Children
686 Bay St., Toronto, ON M5G 0A4
Please click here for abstract submission information
More program information to come.
Cataract Appropriateness and Prioritization Symposium – VIA ZOOM
Date: Friday May 12, 2023 and Saturday May 13, 2023
Time: 9:00 AM
Zoom Link – Register in advance for this webinar:
After registering, you will receive a confirmation email containing information about joining the webinar.
Click here for more information
DOVS ONCOLOGY ROUNDS – VIA ZOOM – Lesions and Images in Ophthalmic Oncology
Date: Monday March 27, 2023
Time: 6:30 PM – 7:30 PM
Topic: Lesions and Images in Ophthalmic Oncology
Speakers: Drs. Krema, Weisbrod, Altomare
Zoom Link – Register in advance for this webinar:
After registering, you will receive a confirmation email containing information about joining the webinar.
OBJECTIVES:
1. To acquaint the attendants of the characteristic imaging findings in ophthalmic tumours
2. To demonstrate the role of different imaging methods in reaching clinical diagnosis in ophthalmic tumours
3. To expand the spectrum of differential diagnosis of ophthalmic tumours by including images of common tumour- like lesions.
4. To provide a summary of the current knowledge about the presented lesions in each session.
Cornea Surgical Video Learning Series – VIA ZOOM – Endothelial Replacement: Yesterday, Today, and Tomorrow
Date: Thursday February 9, 2023
Time: 7:30 PM – 8:30 PM
Topic: Endothelial Replacement: Yesterday, Today, and Tomorrow
Speaker: Martin Dirisamer
Zoom Link – Register in advance for this webinar:
After registering, you will receive a confirmation email containing information about joining the webinar.
DOVS RETINA CONNECT – VIA ZOOM – Retina cases that shock and awe
Date: Tuesday January 24, 2023
Time: 7:30 PM – 8:30 PM
Topic: Retina cases that shock and awe
Speakers: Dr. Jose Pulido
Zoom Link – Register in advance for this webinar:
After registering, you will receive a confirmation email containing information about joining the webinar.
Canadian Ophthalmological Society (COS) Joint position paper calling for a complete ban on scleral tattooing and eyeball jewellery implantation in Manitoba
September 2018
Context: There is a growing trend among body modification enthusiasts to tattoo their eyeballs (specifically the sclera of the eye) and also implant jewellery under the surface layer (conjunctiva) of the eyeball. This is being done unsafely by untrained artists under questionable conditions and leading to a
variety of unfortunate complications, including loss of vision and loss of the eye in some cases. As eye health care professionals, the Manitoba Association of Optometrists (MAO) and the Eye Physicians and Surgeons of Manitoba (EPSOM) are submitting this joint statement calling for a ban of these dangerous practices leading to unnecessary morbidity and loss of vision in members of the unsuspecting public.
Read the Full Position Statement Here
Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada
December 2019
Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada
The Position Stated is based on current evidence and expert medical opinion available at the
time and was endorsed by the COS in November 2019.
Background: As eye disease before age 5 years is common, some form of vision screening should be performed on children before attending primary school. However, the lack of consistent national recommendations creates confusion for patients, eye care professionals, and governments alike.
Download the full guidelines here
Canadian Glaucoma Society Evidence-Based Recommendations for the Risk of Acute Angle Closure Glaucoma with Routine Use of Hyoscine-n-Butylbromide (Buscopan) for Gastroenterological Procedures
November 2019
Evidence-Based Recommendations for the Risk of Acute Angle Closure Glaucoma with Routine Use of Hyoscine-n-Butylbromide (Buscopan) for Gastroenterological Procedures.
The Position Stated is based on current evidence and expert medical opinion available at the time and was endorsed by the COS in November 2019.
Background: Hyoscine-n-butylbromide (Buscopan) is a commonly used anticholinergic medication for
gastroenterological endoscopic procedures because of its ability to induce smooth muscle relaxation and decrease spasm. It can also be used for radiologic procedures of the gastrointestinal tract. Buscopan may increase detection of colorectal adenoma by up to 30%, thus this medication should not be withheld needlessly.